Pharmafile Logo
Pharmafocus logo
Advanced Search

US Senate pass bipartisan bill to tackle opioid crisis

September 18, 2018
Manufacturing and Production Senate, US, epidemic, opioid, opioid crisis, politics

The US Senate have passed a bipartisan bill aimed at combatting the opioid crisis. The bill, which was passed with …

News

US House of Representatives blocks drug pricing advert bill

September 18, 2018
Manufacturing and Production Big Pharma, Drug pricing, HHS, Trump, Twitter, adverts

A ruling which would force pharmaceutical companies to disclose the price of their drugs in television advertisements has been set …

News
novo_nordisk_flag

400 jobs to go as Novo Nordisk overhauls R&D operations

September 18, 2018
Manufacturing and Production, Sales and Marketing Novo Nordisk, pharma

Novo Nordisk has revealed its intention to restructure its research & development operations “to accelerate the expansion and diversification of …

News

Sanofi’s Dupixent improves symptoms for adolescent atopic dermatitis patients

September 17, 2018
Research and Development, Sales and Marketing Dupixent, EADV 2018, Sanofi, atopic dermatitis, pharma

Sanofi’s Dupixent (dupilumab) has made a strong showing as a monotherapy at Phase 3 in the treatment of moderate-to-severe atopic …

News
astrazeneca_plaque

FDA approves AstraZeneca’s Lumoxiti for hairy cell leukaemia (HCL)

September 17, 2018
Sales and Marketing AstraZeneca, HCL, Lumoxiti, leukaemia, rare diseases

AstraZeneca’s Lumoxiti has been approved for use for the treatment of relapsed or refractory hairy cell leukemia (HCL)in adults who …

News
allergan

Allergan acquires neurotoxin specialist Bonti in $195m deal

September 17, 2018
Sales and Marketing Allergan, Bonti, Botox, Neurotoxin, acquisition, deal

The Dublin-headquartered multinational Allergan have agreed to acquire the clinical stage biotech Bonti in a deal worth more than $195 …

News
teva_copy

Teva shares soar after migraine treatment Ajovy approval

September 17, 2018
Sales and Marketing FDA, Teva, US, ajovy, approval, israel

Shares in the Israeli pharma firm Teva soared on Sunday after the announcement that the US Food and Drug Administration …

News

NICE recommends Novartis combo as first-ever BRAF-targeted therapy for advanced post-surgery melanoma

September 17, 2018
Sales and Marketing Cancer, NICE, Novartis, Tafinlar, mekinist, melanoma, pharma

NICE has taken the decision to recommend the first ever first BRAF-targeted therapy for use on the NHS in England …

News
georg-terstappen

Ex-GSK R&D head joins OxStem as CSO

September 14, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, OxStem, University of Oxford

OxStem, a regenerative drug discovery unit spun out from the University of Oxford, has brought on board ex-GlaxoSmithKline R&D exec …

Appointment
manuel_aivado

Aileron Therapeutics name Dr Manuel Aivado as new President and CEO

September 14, 2018
Aileron, CEO, Massachusetts, Watertown, appointments

The Watertown Massachusetts-based stapled peptide therapeutics specialist Aileron Therapeutics has appointed former SVP, Chief Medical & Scientific Officer Dr Manuel …

Appointment

UCB brings promising plaque psoriasis data to EADV 2018

September 14, 2018
Medical Communications, Research and Development EADV 2018, UCB, pharma, psoriasis

UCB has joined in on the wave of new psoriasis data emerging from the European Academy of Dermatology and Venereology …

News
hurricane_florence_credit_nasa

Pfizer, Novartis, MSD, Novo and GSK halt operations in wake of Hurricane Florence

September 14, 2018
Medical Communications GSK, Hurricane Florence, MSD, Novartis, Novo Nordisk, Pfizer, pharma

As Hurricane Florence begins to breach the Southeast Coast, major pharma firms have announced they are enacting contingency plans, including …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

September 14, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bristol-Myers Squibb, FDA, NICE, Novo Nordisk, Spinraza, brexit, bristol myers squibb, top 10

With the Pharmafocus team having avoided hurricane Florence and finally arriving back in the UK just last night, after stopping …

News
glasgow-2997986_960_720

Scottish government invests £11m into Glasgow biotechnology centre

September 14, 2018
Medical Communications Biotechnology, IBioIC, Scotland, glasgow, scottish government

The Scottish government is investing £11 million into the Glasgow-based Industrial Biotechnology Innovation Centre (IBioIC), an innovation centre which facilitates …

News
5204602349_c87b204860_z

FDA launch plan to tackle e-cig epidemic

September 14, 2018
Medical Communications FDA, Scott Gottlieb, USA, e-cig, juul

The FDA have announced a plan to crack down on the so-called ‘e-cig epidemic’, following revelations that vaping and use …

News
carina_web

Living with fibromyalgia

September 13, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing fibromyalgia, patient experience

Scottish comedian Carina MacLeod recounts her life with fibromyalgia and the benefits of comedy in dealing with a chronic condition, …

Feature
ob_logo

Oxford Biomedica to expand with fourth site, creating 100 jobs

September 13, 2018
Oxford BioMedica, pharma

Gene and cell therapy group Oxford Biomedica has announced plans to expand its business with a new site located not …

News
novartis_outside_1

Novartis doubles down on Cosentyx’s efficacy in psoriasis with extensive real-world data

September 13, 2018
Research and Development Cosentyx, Novartis, pharma, psoriasis

Novartis was yet another company to reveal new data on a psoriasis drug at the European Academy of Dermatology and …

News
celgene_1_02

Celgene’s Otezla produces “meaningful benefits” beyond traditional metrics in plaque psoriasis

September 13, 2018
Research and Development Celgene, otezla, pharma, psoriasis

Celgene made its voice heard amongst the chorus of new psoriasis data emerging from the European Academy of Dermatology and …

News
janssen_latest_logo_on_sign

Phase 3 data presents strong case for switching from Humira to Janssen’s Tremfya in plaque psoriasis

September 13, 2018
Research and Development Humira, Janssen, Tremfya, pharma, psoriasis

Janssen has unveiled new Phase 3 data derived from two separate trials on the efficacy and benefits of switching to …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026